American Journal of Neuroradiology, Vol 14, Issue 6 1267-1281, Copyright © 1993 by American Society of Neuroradiology
ARTICLES |
Clinical proton MR spectroscopy of neurodegenerative disease in childhood
AA Tzika, WS Ball Jr, DB Vigneron, RS Dunn and DR Kirks
Department of Radiology, Children's Hospital Medical Center, Cincinnati, OH 45229.
PURPOSE: To determine the contribution of MR spectroscopy in the assessment of childhood neurodegenerative disease. METHODS: Fifty-one subjects (7 weeks to 17 years of age), 22 with either hereditary (n = 16) or acquired (n = 6) neurodegenerative disorders and 29 age-matched control subjects, were studied with combined proton MR spectroscopy and MR imaging. Single-voxel (2.0-8.0 cc) MR spectra were acquired at 1.5 T, with either short-echo-stimulated echoes and/or long-echo spin echoes. RESULTS: MR spectra exhibited signals from n-acetyl-, creatine- , and choline-containing compounds, neurotransmitters (glutamate), intracellular mediators (inositols), and glycolytic products (lactate). Abnormal MR spectra in neurodegenerative disorders reflected: demyelination, neuronal loss, and gliosis (increased mobile lipid presence and reduction of n-acetylaspartate to choline); metabolic acidosis (lactate accumulation); and neurotransmitter neurotoxicity (increased glutamate, glutamine, and inositols). CONCLUSION: Proton MR spectroscopy may complement MR imaging in diagnostic assessment and therapeutic monitoring of neurodegenerative disorders.
This article has been cited by other articles:
![]() |
M. A. A. P. Willemsen, M. van der Graaf, M. S. van der Knaap, A. Heerschap, P. H. M. F. van Domburg, F. J. M. Gabreels, and J. J. Rotteveel MR Imaging and Proton MR Spectroscopic Studies in Sjogren-Larsson Syndrome: Characterization of the Leukoencephalopathy AJNR Am. J. Neuroradiol., April 1, 2004; 25(4): 649 - 657. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. S. Ball Jr PEDIATRIC NEURORADIOLOGY AJNR Am. J. Neuroradiol., January 1, 2000; 21(1): 29 - 36. [Full Text] [PDF] |
||||
![]() |
G Tedeschi, S Bonavita, N W Barton, A Bertolino, J A Frank, N J Patronas, J R Alger, and R Schiffmann Proton magnetic resonance spectroscopic imaging in the clinical evaluation of patients with Niemann-Pick type C disease J. Neurol. Neurosurg. Psychiatry, July 1, 1998; 65(1): 72 - 79. [Abstract] [Full Text] |
||||
![]() |
T. Hashimoto, M. Tayama, M. Miyazaki, Y. Yoneda, T. Yoshimoto, M. Harada, H. Miyoshi, M. Tanouchi, and Y. Kuroda Differences in Brain Metabolites Between Patients With Autism and Mental Retardation as Detected by in Vivo Localized Proton Magnetic Resonance Spectroscopy J Child Neurol, February 1, 1997; 12(2): 91 - 96. [Abstract] [PDF] |
||||


